Evome Medical Technologies (Evome Medical Technologies) Cash, Cash Equivalents, Marketable Securities : $0.69 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Evome Medical Technologies Cash, Cash Equivalents, Marketable Securities?

Evome Medical Technologies's quarterly cash, cash equivalents, marketable securities declined from Jun. 2023 ($1.05 Mil) to Sep. 2023 ($0.78 Mil) but then stayed the same from Sep. 2023 ($0.78 Mil) to Dec. 2023 ($0.69 Mil).

Evome Medical Technologies's annual cash, cash equivalents, marketable securities increased from Feb. 2021 ($5.96 Mil) to Feb. 2022 ($6.34 Mil) but then declined from Feb. 2022 ($6.34 Mil) to Dec. 2023 ($0.69 Mil).

Evome Medical Technologies Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Evome Medical Technologies's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evome Medical Technologies Cash, Cash Equivalents, Marketable Securities Chart

Evome Medical Technologies Annual Data

Trend

Dec14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Dec23

Cash, Cash Equivalents, Marketable Securities

Get a 7-Day Free Trial

7.04

6.92

5.96

6.34

0.69

Evome Medical Technologies Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Mar23	Jun23	Sep23	Dec23
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial															2.33	1.71	1.05	0.78	0.69

Evome Medical Technologies Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Evome Medical Technologies (OTCPK:LNDZF) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Evome Medical Technologies Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Evome Medical Technologies's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.